Avery W. Catlin
2012
In 2012, Avery W. Catlin earned a total compensation of $712.5K as Senior Vice President and Chief Financial Officer at Celldex Therapeutics, a 41% increase compared to previous year.
Compensation breakdown
| Bonus | $85,000 |
|---|---|
| Option Awards | $321,876 |
| Salary | $299,986 |
| Other | $5,643 |
| Total | $712,505 |
Catlin received $321.9K in option awards, accounting for 45% of the total pay in 2012.
Catlin also received $85K in bonus, $300K in salary and $5.6K in other compensation.
Rankings
In 2012, Avery W. Catlin's compensation ranked 7,494th out of 11,487 executives tracked by ExecPay. In other words, Catlin earned more than 34.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,494 out of 11,487 | 35th |
Division Manufacturing | 2,694 out of 4,253 | 37th |
Major group Chemicals And Allied Products | 697 out of 1,203 | 42nd |
Industry group Drugs | 486 out of 925 | 48th |
Industry In Vitro and In Vivo Diagnostic Substances | 23 out of 47 | 51st |
Source: SEC filing on April 23, 2015.
Catlin's colleagues
We found four more compensation records of executives who worked with Avery W. Catlin at Celldex Therapeutics in 2012.